Home Louisiana Bills
Bills

Louisiana Congressional Bills

Browse federal bills sponsored by your state's delegation.

signed · Louisiana · House Nov 11, 2021

HR 3919: Secure Equipment Act of 2021

Secure Equipment Act of 2021 This bill requires the Federal Communications Commission (FCC) to establish rules stating that it will no longer review or approve any authorization application for equipment that is on the list of covered communications equipment or services. (Listed communications equipment or services are those that the FCC determines pose an unacceptable risk to national security or the security and safety of U.S. persons.)
Steve Scalise (R) · 22 co-sponsors
signed · Louisiana · Senate Oct 8, 2021

S 1917: K-12 Cybersecurity Act of 2021

K-12 Cybersecurity Act of 2021 This bill requires the Cybersecurity and Infrastructure Security Agency (CISA) to study the cybersecurity risks facing elementary and secondary schools and develop recommendations that include cybersecurity guidelines designed to assist schools in facing those risks. The use of such recommendations shall be voluntary. The study must evaluate the challenges that schools face in securing (1) information systems owned, leased, or relied upon by those schools; and (2) sensitive student and employee records. Further, the bill requires CISA to (1) develop an online training toolkit designed for school officials; and (2) make available on the Department of Homeland Security website the study's findings, the cybersecurity guidelines, and the toolkit.
Gary C. Peters (D) · 3 co-sponsors
signed · Louisiana · House Aug 25, 2021

HR 1448: PAWS for Veterans Therapy Act

Puppies Assisting Wounded Servicemembers for Veterans Therapy Act or the PAWS for Veterans Therapy Act This bill implements a program and a policy related to service dog therapy for veterans. Specifically, the bill requires the Department of Veterans Affairs (VA) to implement a five-year pilot program to provide canine training to eligible veterans diagnosed with post-traumatic stress disorder as an element of a complementary and integrative health program. Eligible veterans are those who are enrolled in the VA health care system and have been recommended for participation by a qualified mental health care provider or clinical team. The VA must seek to enter agreements containing specified elements with accredited nongovernmental entities that have demonstrated ability to provide canine training. Veterans who participate in the program are authorized to adopt the dog they assisted in training if their health provider determines it is in the best interest of the veteran. The VA must establish processes to document and track the progress of participating veterans with respect to health benefits and improvements. The Government Accountability Office must brief Congress and submit a report on the program. The bill also authorizes the VA to provide service dogs to veterans with mental illnesses, regardless of whether they have a mobility impairment.
Steve Stivers (R) · 317 co-sponsors
signed · Louisiana · Senate Jul 29, 2021

S 957: DUMP Opioids Act

This bill requires the Department of Veterans Affairs (VA) to designate periods during which any individual may dispose of controlled substances medications at VA medical facilities with an on-site pharmacy or a physical location dedicated for law enforcement purposes. The bill also authorizes the VA to carry out public information campaigns regarding the designated disposal periods.
John Kennedy (R) · 1 co-sponsor
signed · Louisiana · Senate Apr 23, 2021

S 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity.

This bill provides statutory authority for the existing Food and Drug Administration (FDA) practice of defining active ingredient more narrowly as active moiety in certain situations, such as when determining whether a new drug is entitled to a market exclusivity period or providing priority review of drugs for treating rare pediatric diseases. Generally, the FDA defines active moiety as the core molecule or ion in a drug responsible for the relevant physiological or pharmacological action. By contrast, the FDA defines an active ingredient as a component in a drug that is intended to furnish pharmacological activity or other direct effect. The FDA's existing practice of interpreting active ingredient as active moiety in certain situations, as statutorily authorized by this bill, tends to exclude some drugs from market exclusivity. The bill replaces references to active ingredient with active moiety in various statutes authorizing FDA activities.
Bill Cassidy (R) · 2 co-sponsors
signed · Louisiana · Senate Apr 23, 2021

S 164: Advancing Education on Biosimilars Act of 2021

Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.) The FDA may also maintain and operate a website to provide educational materials about biological products.
Margaret Wood Hassan (D) · 1 co-sponsor
Showing 85 to 92 of 92 bills
Previous 1 6 7 8